Status: Not yet recruiting
Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection
The goal of this clinical trial is to evaluate the safety and performance of the SAVA Continuous Glucose Monitor across glucose ranges over a period of 15-day wear in adults over 18 years of age with Type 1 Diabetes. This is a pilot study, so the main purposes are to collect preliminary data for future studies, assess comfort and safety, and explore the accuracy of the CGM against references and benchmarks.
Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: SAVA Technologies Ltd.Updated: Jul 1, 2026
Eligibility criteria
The participant is willing and able to give informed consent to participate in t... [+14]
The participant gave birth within the last 6 months, is pregnant, is trying to c... [+14]